Clinical trials
Phase 3 Breast Carcinoma In Situ trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 3 |
| 2005 | 1 |
| 2007 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 2 |
| ETOP IBCSG Partners Foundation | 2 |
| Academic and Community Cancer Research United | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Georgetown University | 1 |
| INSYS Therapeutics Inc | 1 |
| NSABP Foundation Inc | 1 |
| National Cancer Institute (NCI) | 1 |
| National Institute of Oncology, Hungary | 1 |
| North Central Cancer Treatment Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Carcinoma In Situ | 16 |
| Breast Neoplasms | 13 |
| Carcinoma, Intraductal, Noninfiltrating | 10 |
| Breast Neoplasms, Male | 2 |
| Carcinoma, Ductal, Breast | 2 |
| Endometrial Neoplasms | 2 |
| Hot Flashes | 2 |
| Adrenocortical Carcinoma | 1 |
| Anus Neoplasms | 1 |
| Appendiceal Neoplasms | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.